Evidence map›Paper›PMID 30022944›Full record

ArticleCase reports in oncology

Refractory Septic Shock due to Underlying Immunocompromised Disease: A Case of Fatal Peripheral T-Cell Lymphoma Not Otherwise Specified in a Young Hispanic Woman.

Kishore Kumar, Muhammad Saad, Chukwunonso Chime, Kanthi Badipatla, Hassan Tariq, Sureshkumar Nayudu, Masooma Niazi, Sridhar Chilimuri

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kishore KumarDepartment of Medicine, Bronx Lebanon Hospital Center, Bronx, New York, USA.
Muhammad SaadDepartment of Medicine, Bronx Lebanon Hospital Center, Bronx, New York, USA.
Chukwunonso ChimeDepartment of Medicine, Bronx Lebanon Hospital Center, Bronx, New York, USA.
Kanthi BadipatlaDepartment of Medicine, Bronx Lebanon Hospital Center, Bronx, New York, USA.
Hassan TariqDepartment of Medicine, Bronx Lebanon Hospital Center, Bronx, New York, USA.
Sureshkumar NayuduDepartment of Medicine, Bronx Lebanon Hospital Center, Bronx, New York, USA.
Masooma NiaziDepartment of Pathology, Bronx Lebanon Hospital Center, Bronx, New York, USA.
Sridhar ChilimuriDepartment of Medicine, Bronx Lebanon Hospital Center, Bronx, New York, USA.
Bronx-Lebanon Hospital Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) is known as an unclassified group of non-Hodgkin lymphomas. PTCL-NOS is a subtype of peripheral T-cell lymphoma that accounts for 3% of all lymphomas in the United States. PTCL-NOS commonly presents as a disseminated disease, B symptoms (fever, night sweats, and weight loss), generalized lymphadenopathy, bone marrow infiltration, and extranodal involvement. Other rare and possible manifestations include peripheral eosinophilia, pruritus, or hemophagocytic syndrome. This type of lymphoma is aggressive in nature and carries a high mortality rate. There is no established standard-of-care treatment protocol for PTCL-NOS, several chemotherapy drug combinations are frequently used as a frontline treatment with an overall 5-year survival rate of 25%. We present a case of a 35-year old Hispanic woman who initially presented with a chief complaint of bilateral lower extremity swelling due to hypoalbuminemia and new-onset hyperkeratotic skin of the palms and soles.

Indexed as

Non-Hodgkin lymphomaRefractory shockT-cell lymphoma not otherwise specified

Identifiers

PMID30022944
PMCPMC6047556
OpenAlexW2809193437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.